NEU NEWMARKET CORP
Industrial Organic Chemicals · NYSE · SEC CIK 1282637 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY0.9%
TTM net income YoY2.0%
TTM EPS YoY4.1%
Revenue 3-yr CAGR0.4%
Net income 3-yr CAGR4.6%
Margins
Gross margin31.7%
Operating margin20.2%
Net margin16.5%
FCF margin13.8%
EBITDA margin24.8%
Returns
ROE25.3%
ROA13.3%
ROIC (approx.)17.3%
Asset turnover0.80x
Leverage & solvency
Liabilities / assets47.1%
Debt / equity0.43x
Current ratio2.46x
Interest coverage15.79x
Cash quality & payout
Operating cash flow / net income1.09x
Accruals ratio-1.2%
Payout ratio24.4%
Capex / revenue4.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $2.73B | $2.79B |
| Cost of revenue | $1.87B | $1.90B |
| Gross profit | $857.40M | $886.35M |
| R&D expense | $132.09M | $124.90M |
| SG&A expense | $181.58M | $171.41M |
| Operating income | $543.73M | $590.04M |
| Interest expense | $39.69M | $57.37M |
| Pretax income | $560.56M | $584.11M |
| Income tax | $141.81M | $121.69M |
| Net income | $418.75M | $462.41M |
| EBITDA | $666.15M | $706.99M |
| EPS (basic) | 44.44 | 48.22 |
| EPS (diluted) | 44.44 | 48.22 |
| Dividends declared per share | 11.25 | 10.00 |
| Weighted avg. shares (diluted) | 9.39M | 9.55M |
| Balance sheet | ||
| Cash & equivalents | $77.60M | $77.48M |
| Receivables | $422.08M | $395.45M |
| Inventory | $502.26M | $505.43M |
| Current assets | $1.06B | $1.03B |
| PP&E, net | $775.48M | $735.36M |
| Total assets | $3.49B | $3.13B |
| Current liabilities | $419.28M | $374.48M |
| Long-term debt | $883.39M | $971.28M |
| Total debt | $883.39M | $971.28M |
| Total liabilities | $1.71B | $1.67B |
| Shareholders' equity | $1.78B | $1.46B |
| Net debt | $805.79M | $893.80M |
| Shares outstanding | 9.40M | 9.52M |
| Cash flow statement | ||
| Operating cash flow | $568.97M | $519.59M |
| Capital expenditure | $77.64M | $57.32M |
| Free cash flow | $491.33M | $462.27M |
| Investing cash flow | -$291.08M | -$738.80M |
| Financing cash flow | -$279.14M | $185.81M |
| Depreciation & amortization | $122.42M | $116.96M |
| Dividends paid | $105.93M | $95.90M |
| Share buybacks | $77.22M | $31.91M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.